Surgical Science Sweden AB (SUS) — Cash Flow Quality Index
Surgical Science Sweden AB (SUS) has a Cash Flow Quality Index of 2.19x as of December 2025. Operating cash flow of Skr72.89 Million exceeds net income of Skr33.26 Million, indicating high earnings quality where cash backs reported profits. Explore Surgical Science Sweden AB cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Surgical Science Sweden AB Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Surgical Science Sweden AB across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Surgical Science Sweden AB (SUS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Surgical Science Sweden AB (2015–2025)
Year-by-year earnings quality comparison for Surgical Science Sweden AB. For live market cap and the full company financial profile, see Surgical Science Sweden AB market cap and net worth.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.19x | Skr79.80 Million | Skr66.82 Million | ▲ +14.6% |
| 2024 | 1.04x | Skr137.22 Million | Skr131.65 Million | ▲ +2.3% |
| 2023 | 1.02x | Skr238.29 Million | Skr233.97 Million | ▲ +27.8% |
| 2022 | 0.80x | Skr129.49 Million | Skr162.54 Million | ▲ +15.2% |
| 2021 | 0.69x | Skr39.08 Million | Skr56.52 Million | ▼ -40.5% |
| 2020 | 1.16x | Skr23.23 Million | Skr19.97 Million | ▼ -68.0% |
| 2019 | 3.64x | Skr55.20 Million | Skr15.18 Million | ▼ -12.7% |
| 2015 | 4.17x | Skr7.50 Million | Skr1.80 Million | — |